1
|
Sghier AB, Samba S, Bouabid M, Mouhib N, Berhili S, Moukhlissi M, Mezouar L. Primary cerebral melanoma: An exceptional localization in a case report. Radiol Case Rep 2024; 19:1674-1678. [PMID: 38384706 PMCID: PMC10877127 DOI: 10.1016/j.radcr.2024.01.049] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/26/2023] [Revised: 01/17/2024] [Accepted: 01/18/2024] [Indexed: 02/23/2024] Open
Abstract
Cerebral melanoma is often related to a secondary location of a cutaneous or mucosal melanoma. However, primary cerebral melanoma is a very rare clinical situation, representing less than 1% of all melanomas and 0.07% of all cerebral tumors. The diagnosis of a primary cerebral melanoma therefore requires rigorous clinical and paraclinical investigations. We report a case of primary cerebral melanoma treated in our onco-radiotherapy department.
Collapse
Affiliation(s)
- Ahmed Ben Sghier
- Radiotherapy Department, Mohammed VI University Hospital, Faculty of Medicine and Pharmacy, Mohammed 1st University Oujda, Morocco
| | - Soumiya Samba
- Radiotherapy Department, Mohammed VI University Hospital, Faculty of Medicine and Pharmacy, Mohammed 1st University Oujda, Morocco
| | - Meriem Bouabid
- Radiotherapy Department, Mohammed VI University Hospital, Faculty of Medicine and Pharmacy, Mohammed 1st University Oujda, Morocco
| | - Nourelhouda Mouhib
- Radiotherapy Department, Mohammed VI University Hospital, Faculty of Medicine and Pharmacy, Mohammed 1st University Oujda, Morocco
| | - Soufiane Berhili
- Radiotherapy Department, Mohammed VI University Hospital, Faculty of Medicine and Pharmacy, Mohammed 1st University Oujda, Morocco
| | - Mohamed Moukhlissi
- Radiotherapy Department, Mohammed VI University Hospital, Faculty of Medicine and Pharmacy, Mohammed 1st University Oujda, Morocco
| | - Loubna Mezouar
- Radiotherapy Department, Mohammed VI University Hospital, Faculty of Medicine and Pharmacy, Mohammed 1st University Oujda, Morocco
| |
Collapse
|
2
|
Ben Sghier A, Samba S, Bouabid M, Berhili S, Moukhlissi M, Mezouar L. Cutaneous metastasis of lung cancer: Case report. Radiol Case Rep 2024; 19:1208-1210. [PMID: 38259707 PMCID: PMC10801123 DOI: 10.1016/j.radcr.2023.12.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/15/2023] [Revised: 11/29/2023] [Accepted: 12/06/2023] [Indexed: 01/24/2024] Open
Abstract
Lung cancer is one of the most common cancers in men, and is often diagnosed at the metastatic stage. It often leads to lung, bone, brain, liver, and adrenal metastases. However, unusual secondary locations are possible, such as skin metastases, which are often associated with a poor prognosis. We report a case of lung cancer revealed by a subcutaneous mass on the forehead.
Collapse
Affiliation(s)
- Ahmed Ben Sghier
- Radiotherapy Department, Faculty of Medicine and Pharmacy, University Mohamed VI Hospital, Mohamed First University Oujda, Morocco
| | - Soumiya Samba
- Radiotherapy Department, Faculty of Medicine and Pharmacy, University Mohamed VI Hospital, Mohamed First University Oujda, Morocco
| | - Meriem Bouabid
- Radiotherapy Department, Faculty of Medicine and Pharmacy, University Mohamed VI Hospital, Mohamed First University Oujda, Morocco
| | - Soufiane Berhili
- Radiotherapy Department, Faculty of Medicine and Pharmacy, University Mohamed VI Hospital, Mohamed First University Oujda, Morocco
| | - Mohamed Moukhlissi
- Radiotherapy Department, Faculty of Medicine and Pharmacy, University Mohamed VI Hospital, Mohamed First University Oujda, Morocco
| | - Loubna Mezouar
- Radiotherapy Department, Faculty of Medicine and Pharmacy, University Mohamed VI Hospital, Mohamed First University Oujda, Morocco
| |
Collapse
|
3
|
Bouabid M, Margoum S, BenSghier A, Miry N, Bennani A, Moukhlissi M, Berhili S, Mezouar L. Multimodal Therapy of Locally-Advanced Penile Cancer: A Case Report With Literature Review. Cureus 2024; 16:e57163. [PMID: 38681381 PMCID: PMC11056019 DOI: 10.7759/cureus.57163] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 03/28/2024] [Indexed: 05/01/2024] Open
Abstract
Cancer of the penis is a rare tumor that occurs in the elderly. Because of its rarity, it is often not diagnosed early, and its treatment poses difficulties for practicing oncologists. We report the case of an elderly patient treated for locally advanced squamous cell carcinoma (SCC) of the penis, with a review of the literature. A 71-year-old man, who had been complaining of pruritus on the penis two years ago, presented with an ulcerated lesion on the prepuce and the glans. A biopsy of the lesion with pathological study showed a SCC of the penis. Pelvic MRI showed tumor thickening centered on the glans of the penis, infiltrating the fascia and the spongy urethra with discrete upstream dilatation and bilateral inguinal adenomegaly. CT scan of the neck, chest, abdomen, and pelvis showed no secondary localizations. Treatment initially consisted of carcinological surgery by a partial penectomy with bilateral inguinal lymph node dissection. The tumor was therefore classified as pT3N3M0. A PET CT scan performed later was in favor of local and regional recurrence. Surgery was not feasible, so concomitant chemo-radiotherapy was indicated at a total dose of 70 Gy in 35 fractions of 2 Gy concomitantly with platinum-based chemotherapy, withgood evolution.
Collapse
Affiliation(s)
- Meriem Bouabid
- Department of Radiation Oncology, Centre Hospitalier Universitaire Mohammed VI, Oujda, MAR
| | - Souad Margoum
- Department of Radiation Oncology, Centre Hospitalier Universitaire Mohammed VI, Oujda, MAR
| | - Ahmed BenSghier
- Department of Radiation Oncology, Centre Hospitalier Universitaire Mohammed VI, Oujda, MAR
| | - Nadir Miry
- Department of Pathology, Centre Hospitalier Universitaire Mohammed VI, Oujda, MAR
| | - Amal Bennani
- Department of Pathology, Centre Hospitalier Universitaire Mohammed VI, Oujda, MAR
| | - Mohamed Moukhlissi
- Department of Radiation Oncology, Centre Hospitalier Universitaire Mohammed VI, Oujda, MAR
| | - Soufiane Berhili
- Department of Radiation Oncology, Centre Hospitalier Universitaire Mohammed VI, Oujda, MAR
| | - Loubna Mezouar
- Department of Radiation Oncology, Centre Hospitalier Universitaire Mohammed VI, Oujda, MAR
| |
Collapse
|
4
|
Samba S, Guerrouaz MA, Bensghier A, Berhili S, Moukhlissi M, Mezouar L. Adenoid Cystic Carcinoma of the Vulva: A Case Report. Cureus 2024; 16:e56048. [PMID: 38606234 PMCID: PMC11008925 DOI: 10.7759/cureus.56048] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 03/12/2024] [Indexed: 04/13/2024] Open
Abstract
Adenoid cystic carcinoma (ACC) of the vulva represents a highly uncommon type of female malignancy. Due to the absence of specific treatment guidelines, such cases are typically managed by the treatment protocols for vulvar cancer. Here, we report the case of a 52-year-old woman who presented with a painful right vulvar mass, leading to a diagnosis of ACC of the vulva after biopsy and immunohistochemical analysis. She underwent vulvectomy, bilateral inguinal lymphadenectomy, and targeted radiotherapy, and no evidence of recurrence has been found for three years, with ongoing monitoring for post-radiation effects. This case adds valuable insights into the management of ACC of the vulva and underscores the need for further research and guideline development to optimize care for future patients.
Collapse
Affiliation(s)
- Soumiya Samba
- Department of Radiation Oncology, Centre Hospitalier Universitaire Mohammed VI, Oujda, MAR
| | | | - Ahmed Bensghier
- Department of Radiation Oncology, Centre Hospitalier Universitaire Mohammed VI, Oujda, MAR
| | - Soufiane Berhili
- Department of Radiation Oncology, Faculty of Medicine and Pharmacy, Mohammed First University, Oujda, MAR
| | - Mohamed Moukhlissi
- Department of Radiotherapy, Centre Hospitalier Universitaire Mohammed VI, Oujda, MAR
| | - Loubna Mezouar
- Department of Radiation Oncology, Centre Hospitalier Universitaire Mohammed VI, Oujda, MAR
| |
Collapse
|
5
|
Samba S, Bensghier A, Margoum S, Berhili S, Moukhlissi M, Mezouar L. Exploring Head and Neck Paraganglioma: A Case Report. Cureus 2024; 16:e55720. [PMID: 38586626 PMCID: PMC10998543 DOI: 10.7759/cureus.55720] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 03/07/2024] [Indexed: 04/09/2024] Open
Abstract
Paragangliomas (PGLs) are tumors that are rarely malignant; the majority of them are benign. Similar to pheochromocytoma, they develop from the autonomic nerve system. This system originates from neural crest cells and can undergo neoplastic transformation. PGLs can arise either inside or outside the adrenal glands. Head and neck PGLs are very scarce. The primary locations where this tumor commonly originates within this region are the carotid body, jugular bulb, and vagal body. Hence, in our case report, we attempt to highlight the uncommon presentation of this disease in a 46-year-old female, who initially presented with hypertension and persistent dysphonia. The patient underwent successful external radiotherapy. This case report aims to raise awareness of the characteristics of these rare malignancies.
Collapse
Affiliation(s)
- Soumiya Samba
- Department of Radiation Oncology, Mohammed VI University Hospital, Oujda, MAR
- Faculty of Medicine and Pharmacy, Mohammed First University, Oujda, MAR
| | - Ahmed Bensghier
- Department of Radiation Oncology, Mohammed VI University Hospital, Oujda, MAR
- Faculty of Medicine and Pharmacy, Mohammed First University, Oujda, MAR
| | - Souad Margoum
- Department of Radiation Oncology, Mohammed VI University Hospital, Oujda, MAR
- Faculty of Medicine and Pharmacy, Mohammed First University, Oujda, MAR
| | - Soufiane Berhili
- Department of Radiation Oncology, Mohammed VI University Hospital, Oujda, MAR
- Faculty of Medicine and Pharmacy, Mohammed First University, Oujda, MAR
| | - Mohamed Moukhlissi
- Department of Radiation Oncology, Mohammed VI University Hospital, Oujda, MAR
- Faculty of Medicine and Pharmacy, Mohammed First University, Oujda, MAR
| | - Loubna Mezouar
- Department of Radiation Oncology, Mohammed VI University Hospital, Oujda, MAR
- Faculty of Medicine and Pharmacy, Mohammed First University, Oujda, MAR
| |
Collapse
|
6
|
Sghier AB, Samba S, Bouabid M, Berhili S, Moukhlissi M, Mezouar L. A rare presentation of esthesioneuroblastoma: a case report and review of the literature. Pan Afr Med J 2023; 46:111. [PMID: 38465014 PMCID: PMC10924622 DOI: 10.11604/pamj.2023.46.111.42205] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/18/2023] [Accepted: 12/07/2023] [Indexed: 03/12/2024] Open
Abstract
Esthesioneuroblastoma is a rare malignant tumor developing from the olfactory neuroepithelium. It represents less than 5% of all cancers of the nasal cavity. We are going to report the observation of a patient followed at the regional oncology center of Oujda in Morocco who presented a locally advanced esthesioneuroblastoma. Treatment consisted of surgical resection followed by adjuvant radiotherapy on the tumor bed. Currently, the patient is in good control of his disease.
Collapse
Affiliation(s)
- Ahmed Ben Sghier
- Radiotherapy Department University Mohamed VI Hospital, Faculty of Medicine and Pharmacy, Mohamed First University Oujda, Oujda, Morocco
| | - Soumiya Samba
- Radiotherapy Department University Mohamed VI Hospital, Faculty of Medicine and Pharmacy, Mohamed First University Oujda, Oujda, Morocco
| | - Meriem Bouabid
- Radiotherapy Department University Mohamed VI Hospital, Faculty of Medicine and Pharmacy, Mohamed First University Oujda, Oujda, Morocco
| | - Soufiane Berhili
- Radiotherapy Department University Mohamed VI Hospital, Faculty of Medicine and Pharmacy, Mohamed First University Oujda, Oujda, Morocco
| | - Mohammed Moukhlissi
- Radiotherapy Department University Mohamed VI Hospital, Faculty of Medicine and Pharmacy, Mohamed First University Oujda, Oujda, Morocco
| | - Loubna Mezouar
- Radiotherapy Department University Mohamed VI Hospital, Faculty of Medicine and Pharmacy, Mohamed First University Oujda, Oujda, Morocco
| |
Collapse
|
7
|
Bouabid M, Moukhlissi M, Bensghir A, Samba S, Berhili S, Mezouar L. Pure mediastinal seminoma about a case report. Radiol Case Rep 2023; 18:3565-3571. [PMID: 37577076 PMCID: PMC10412719 DOI: 10.1016/j.radcr.2023.07.036] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/28/2023] [Revised: 07/15/2023] [Accepted: 07/18/2023] [Indexed: 08/15/2023] Open
Abstract
Mediastinal Seminoma is one of the malignant germ cell tumors of the mediastinum. It is a rare tumor that represents only 1%-4% of mediastinal tumors. We report the case of a patient treated at the Oncology Center of Oujda for a pure primitive seminoma of the mediastinum, with a review of the literature to assess the epidemiological, clinical, therapeutic, and prognostic characteristics of this pathology. This is a 25-year-old man whose aunt is being treated for breast cancer and who complained of persistent dry cough with asthenia without any other associated signs. The initial imaging revealed a voluminous locally advanced tumor process in the anterior and middle mediastinum. Tumor markers Alpha-fetoprotein (AFP) and beta-subunit of chorionic gonadotrophic hormone (BHCG) were normal, as well as testicular ultrasound. The CT- guided transthoracic biopsy with anatomopathological study and immunohistochemistry was in favor of a pure seminoma. The treatment consisted of primary chemotherapy with BEP protocol. The response was favorable with a significant reduction in tumor size estimated at 90%. The residual tumor was inoperable due to its intimate contact with the vascular structures and was treated with external radiotherapy at a total dose of 36 Gy. The evolution at 20 months after treatment was in favor of a good clinical and radiological evolution.
Collapse
Affiliation(s)
- Meriem Bouabid
- Department of Radiotherapy, Faculty of Medicine Oujda, Hassan II Oncology Center, Mohammed VI Hospital Center of Oujda, Mohammed 1st University Oujda, Morocco
| | - Mohamed Moukhlissi
- Department of Radiotherapy, Faculty of Medicine Oujda, Hassan II Oncology Center, Mohammed VI Hospital Center of Oujda, Mohammed 1st University Oujda, Morocco
| | - Ahmed Bensghir
- Department of Radiotherapy, Faculty of Medicine Oujda, Hassan II Oncology Center, Mohammed VI Hospital Center of Oujda, Mohammed 1st University Oujda, Morocco
| | - Soumya Samba
- Department of Radiotherapy, Faculty of Medicine Oujda, Hassan II Oncology Center, Mohammed VI Hospital Center of Oujda, Mohammed 1st University Oujda, Morocco
| | - Soufiane Berhili
- Department of Radiotherapy, Faculty of Medicine Oujda, Hassan II Oncology Center, Mohammed VI Hospital Center of Oujda, Mohammed 1st University Oujda, Morocco
| | - Loubna Mezouar
- Department of Radiotherapy, Faculty of Medicine Oujda, Hassan II Oncology Center, Mohammed VI Hospital Center of Oujda, Mohammed 1st University Oujda, Morocco
| |
Collapse
|
8
|
El Youssi Z, Mansouri H, Elouaouch S, Moukhlissi M, Berhili S, Mezouar L. Early-Stage Primary Rectal Melanoma: A Case Report. Cureus 2023; 15:e42629. [PMID: 37641758 PMCID: PMC10460638 DOI: 10.7759/cureus.42629] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 07/28/2023] [Indexed: 08/31/2023] Open
Abstract
Malignant primary rectal melanomas (PRM) are rare tumors. Their diagnosis is frequently delayed as these lesions are often mistaken for benign diseases, resulting in extremely poor overall survival. Histological evaluation with special immunohistochemical (IHC) stains is often indispensable for a definitive diagnosis. The main treatment for this condition involves surgical resection. Adjuvant therapy has also been long recommended. We discuss the case of a 60-year-old woman who presented with changes in bowel habits, anal pain, and perineal burning with no bleeding. A digital rectal examination revealed a nodular mass extending 5 cm from the anal verge. Rectosigmoidoscopy demonstrated an ulcerated polypoid tumor extending 4 cm from the anal verge and over 5 cm into the lower rectum. Biopsy and IHC tests confirmed the diagnosis of rectal melanoma. The patient was successfully managed with surgery followed by external beam radiotherapy and a complete response was achieved after 10 months of follow-up.
Collapse
Affiliation(s)
- Zahira El Youssi
- Radiation Oncology, Mohammed VI University Hospital, Faculty of Medicine and Pharmacy, Mohammed I University of Oujda, Oujda, MAR
| | - Hanane Mansouri
- Radiation Oncology, Mohammed VI University Hospital, Faculty of Medicine and Pharmacy, Mohammed I University of Oujda, Oujda, MAR
| | - Sofia Elouaouch
- Radiation Oncology, Mohammed VI University Hospital, Faculty of Medicine and Pharmacy, Mohammed I University of Oujda, Oujda, MAR
| | - Mohammed Moukhlissi
- Radiation Oncology, Mohammed VI University Hospital, Faculty of Medicine and Pharmacy, Mohammed I University of Oujda, Oujda, MAR
| | - Soufiane Berhili
- Radiation Oncology, Mohammed VI University Hospital, Faculty of Medicine and Pharmacy, Mohammed I University of Oujda, Oujda, MAR
| | - Loubna Mezouar
- Radiation Oncology, Mohammed VI University Hospital, Faculty of Medicine and Pharmacy, Mohammed I University of Oujda, Oujda, MAR
| |
Collapse
|
9
|
Elouaouch S, El Youssi Z, Mansouri H, Nadir M, Bennani A, Guerrouaz MA, Moukhlissi M, Berhili S, Mezouar L. Localized Hidradenocarcinoma of the Scalp: A Case Report. Cureus 2023; 15:e38675. [PMID: 37288227 PMCID: PMC10243552 DOI: 10.7759/cureus.38675] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 05/07/2023] [Indexed: 06/09/2023] Open
Abstract
Hidradenocarcinomas or malignant hidradenomas are tumors developed from the sweat glands, in particular, the eccrine glands. It is a rare entity of skin tumors and frequently appears de novo with a slight female predominance and an average age of 50 years at diagnosis. We report the case of a 57-year-old woman treated for localized hidradenocarcinoma of the scalp, successfully managed by surgery and adjuvant radiotherapy.
Collapse
Affiliation(s)
- Sofia Elouaouch
- Radiation Oncology, Mohammed VI University Hospital, Faculty of Medicine and Pharmacy of Oujda, Mohammed First University of Oujda, Oujda, MAR
| | - Zahira El Youssi
- Radiation Oncology, Mohammed VI University Hospital, Faculty of Medicine and Pharmacy of Oujda, Mohammed First University of Oujda, Oujda, MAR
| | - Hanane Mansouri
- Radiation Oncology, Mohammed VI University Hospital, Faculty of Medicine and Pharmacy of Oujda, Mohammed First University of Oujda, Oujda, MAR
| | - Miry Nadir
- Anatomopathology, Faculty of Medicine and Pharmacy of Oujda, Mohammed First University of Oujda, Oujda, MAR
| | - Amal Bennani
- Anatomopathology, Faculty of Medicine and Pharmacy of Oujda, Mohammed First University of Oujda, Oujda, MAR
| | | | - Mohamed Moukhlissi
- Radiation Oncology, Mohammed VI University Hospital, Faculty of Medicine and Pharmacy of Oujda, Mohammed First University of Oujda, Oujda, MAR
| | - Soufiane Berhili
- Radiation Oncology, Mohammed VI University Hospital, Faculty of Medicine and Pharmacy of Oujda, Mohammed First University of Oujda, Oujda, MAR
| | - Loubna Mezouar
- Radiation Oncology, Mohammed VI University Hospital, Faculty of Medicine and Pharmacy of Oujda, Mohammed First University of Oujda, Oujda, MAR
| |
Collapse
|
10
|
Moukhlissi M, Ben sghier A, Serji B, El Harroudi T, Bennani A, Dahbi Z, Berhilli S, Mezouar L. A giant primary vaginal sarcoma: A report case and literature review. Radiol Case Rep 2023; 18:1872-1876. [PMID: 36936806 PMCID: PMC10017309 DOI: 10.1016/j.radcr.2023.02.024] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/28/2022] [Revised: 02/07/2023] [Accepted: 02/08/2023] [Indexed: 03/09/2023] Open
Abstract
Primary vaginal sarcoma is a rare disease entity, reported in less than 3% of cases of vaginal cancers. We report the observation of a patient treated at the regional oncology center of Oujda in Morocco who is presented with a non-metastatic primary vaginal leiomyosarcoma of 20 cm. The treatment consisted of neoadjuvant chemotherapy, followed by hemostatic surgery with tumor resection limits, reinforced by radiotherapy and then a surgical resection with a tumor resection taking away the infiltrated part of the anterior face of the lower rectum and the realization of a left iliac colostomy whose resected tumor part limits were healthy. At present, the patient is 4 years of follow-up without locoregional or distant recurrence.
Collapse
Affiliation(s)
- Mohamed Moukhlissi
- Radiotherapy Department, University Mohamed VI Hospital, Mohamed First University Oujda, Oujda, Morocco
- Corresponding author.
| | - Ahmed Ben sghier
- Radiotherapy Department, University Mohamed VI Hospital, Mohamed First University Oujda, Oujda, Morocco
| | - Badr Serji
- Surgery Department, University Mohamed VI Hospital, Mohamed First University Oujda, Oujda, Morocco
| | - Tijani El Harroudi
- Surgery Department, University Mohamed VI Hospital, Mohamed First University Oujda, Oujda, Morocco
| | - Amal Bennani
- Anatomopathology Department, University Mohamed VI Hospital, Mohamed First University Oujda, Oujda, Morocco
| | - Zineb Dahbi
- Radiotherapy Department, Mohammed VI University of Health Sciences, Casablanca, Morocco
| | - Soufinae Berhilli
- Radiotherapy Department, University Mohamed VI Hospital, Mohamed First University Oujda, Oujda, Morocco
| | - Loubna Mezouar
- Radiotherapy Department, University Mohamed VI Hospital, Mohamed First University Oujda, Oujda, Morocco
| |
Collapse
|
11
|
Moukhlissi M, Samba S, Najioui Y, Bennani A, Berhili S, Mezouar L. [A rare case of botryoid sarcoma of the uterine cervix: case report]. Pan Afr Med J 2023; 44:102. [PMID: 37250679 PMCID: PMC10219833 DOI: 10.11604/pamj.2023.44.102.37239] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/07/2022] [Accepted: 02/01/2023] [Indexed: 05/31/2023] Open
Abstract
Botryoid sarcoma is a subtype of rhabdomyosarcoma affecting soft tissues and exceptionally the cervix. We here report the case of an 18-year-old female patient presenting to the emergency department with a feeling of pelvic heaviness, metrorrhagia and urinary retention. Gynecological examination showed budding mass of the uterine cervix. The biopsy showed botryoid sarcoma. Radiological evaluation revealed heterodense cervico-isthmic corporeal mass measuring 97 / 87 mm, without adenopathies or effusions or tumors at other sites. Treatment involved neoadjuvant chemotherapy with vincristine - adriamycin and cyclophosphamide (V-A-C), followed by surgery (total hysterectomy without adnexal preservation). After a follow-up of 3 years, the patient is still in clinical and radiological remission.
Collapse
Affiliation(s)
- Mohamed Moukhlissi
- Département de Radiothérapie, Centre Régional d’Oncologie, CHU Mohammed VI, Faculté de Médecine et de Pharmacie, Université Mohamed Premier Oujda, Oujda, Maroc
| | - Soumya Samba
- Département de Radiothérapie, Centre Régional d’Oncologie, CHU Mohammed VI, Faculté de Médecine et de Pharmacie, Université Mohamed Premier Oujda, Oujda, Maroc
| | - Younesse Najioui
- Département d’Anatomie Pathologique, CHU Mohammed VI, Université Mohamed Premier Oujda, Oudja, Maroc
| | - Amal Bennani
- Département d’Anatomie Pathologique, CHU Mohammed VI, Université Mohamed Premier Oujda, Oudja, Maroc
| | - Soufiane Berhili
- Département de Radiothérapie, Centre Régional d’Oncologie, CHU Mohammed VI, Faculté de Médecine et de Pharmacie, Université Mohamed Premier Oujda, Oujda, Maroc
| | - Loubna Mezouar
- Département de Radiothérapie, Centre Régional d’Oncologie, CHU Mohammed VI, Faculté de Médecine et de Pharmacie, Université Mohamed Premier Oujda, Oujda, Maroc
| |
Collapse
|
12
|
Moukhlissi M, Mansouri H, Najioui Y, Bennani A, Berhili S, Mezouar L. Osteosarcoma of the ethmoid sinus: About a case. Radiol Case Rep 2023; 18:1617-1619. [PMID: 36865619 PMCID: PMC9971021 DOI: 10.1016/j.radcr.2023.01.055] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/26/2022] [Revised: 01/11/2023] [Accepted: 01/12/2023] [Indexed: 02/17/2023] Open
Abstract
Osteosarcomas of the craniofacial bones account for less than 10% of all osteosarcomas. Primary osteosarcomas of the nasal cavity and paranasal sinus are rare localization (0.5%-8.1% of osteosarcomas occur in this site). Accordingly, we report a case of osteosarcoma arising de novo from the ethmoid bone in a 46-year-old female. Initially, she presented with headache, bilateral epistaxis, and postnasal drip. Biopsy revealed an osteosarcoma ethmoidal. The patient was treated by a neoadjuvant chemotherapy followed by surgical resection and radiotherapy.
Collapse
Affiliation(s)
- Mohamed Moukhlissi
- Departement of Radiotherapy, Hassan II Oncology Center, Mohammed VI University hospital Center, Mohamed First University, Oujda, Morocco,Corresponding author at: Departement of Radiotherapy, Hassan II Oncology Center, Mohammed VI University hospital Center, Mohamed First University, Oujda, Morocco.
| | - Hanane Mansouri
- Departement of Radiotherapy, Hassan II Oncology Center, Mohammed VI University hospital Center, Mohamed First University, Oujda, Morocco
| | - Younesse Najioui
- Departement of Anatomo-Pathology, Mohammed VI University hospital center, Mohamed First University, Oujda, Morocco
| | - Amal Bennani
- Departement of Anatomo-Pathology, Mohammed VI University hospital center, Mohamed First University, Oujda, Morocco
| | - Soufiane Berhili
- Departement of Radiotherapy, Hassan II Oncology Center, Mohammed VI University hospital Center, Mohamed First University, Oujda, Morocco
| | - Loubna Mezouar
- Departement of Radiotherapy, Hassan II Oncology Center, Mohammed VI University hospital Center, Mohamed First University, Oujda, Morocco
| |
Collapse
|
13
|
Moukhlissi M, Elouaouch S, Aichouni N, Berhili S, Mezouar L. Hemangiopericytoma of the central nervous system: a case report. Pan Afr Med J 2023; 44:58. [PMID: 37128618 PMCID: PMC10148174 DOI: 10.11604/pamj.2023.44.58.36813] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/14/2022] [Accepted: 01/01/2023] [Indexed: 02/04/2023] Open
Abstract
Hemangiopericytomas or solitary meningeal fibrous tumors are extremely rare mesenchymal tumors. They represent only 1.6% of all central nervous system tumors, occurring mainly in adults between 40 and 50 years of age with a slight male predominance. We report the observation of a 20-year-old man treated at the Oujda Regional Oncology Center for cerebral hemangiopericytoma, revealed by headaches resistant to usual analgesic treatments without other associated signs. Initial imaging a left temporo-parieto-occipital intraaxial tumor process all responsible for a sub-falcoial and temporal engagement whose appearance first evokes a high-grade glial tumor. The patient received a complete excision whose pathological examination with immunohistochemical study was in favor of a grade III hemangiopericytoma according to the WHO 2016 classification. Therapeutic management with adjuvant radiotherapy was supplemented with a volumetric modulated arc therapy (VMAT) technique at a total dose of 54Gy. We will discuss through this case, the clinical and therapeutic peculiarities by a review of the literature.
Collapse
Affiliation(s)
- Mohamed Moukhlissi
- Department of Radiotherapy, Hassan II Regional Oncology Center, Mohammed VI University Hospital, Mohammed First University, Oujda, Morocco
- Corresponding author: Mohamed Moukhlissi, Department of Radiotherapy, Hassan II Regional Oncology Center, Mohammed VI University Hospital, Mohammed First University, Oujda, Morocco.
| | - Sofia Elouaouch
- Department of Radiotherapy, Hassan II Regional Oncology Center, Mohammed VI University Hospital, Mohammed First University, Oujda, Morocco
| | - Narjiss Aichouni
- Department of Radiology, Mohammed VI University Hospital, Mohammed First University, Oujda, Morocco
| | - Soufiane Berhili
- Department of Radiotherapy, Hassan II Regional Oncology Center, Mohammed VI University Hospital, Mohammed First University, Oujda, Morocco
| | - Loubna Mezouar
- Department of Radiotherapy, Hassan II Regional Oncology Center, Mohammed VI University Hospital, Mohammed First University, Oujda, Morocco
| |
Collapse
|
14
|
Berhili S, Mouden K, Moukhlissi M, Harroudi TE, Mezouar L. Primary transitional cell carcinoma of the endometrium: Exceptional presentation of a rare tumor. Radiol Case Rep 2023; 18:205-208. [PMCID: PMC9633738 DOI: 10.1016/j.radcr.2022.10.030] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2022] [Revised: 10/05/2022] [Accepted: 10/08/2022] [Indexed: 11/07/2022] Open
Affiliation(s)
- Soufiane Berhili
- Faculty of Medicine, Mohammed Premier University, Oujda, Morocco
- Department of Radiotherapy, Hassan II Oncology Center, CHU Mohammed VI, PK8 Jerada Rd, 60000, Oujda, Morocco
- Corresponding author.
| | - Karima Mouden
- Department of Radiotherapy, Beni Mellal Oncology Center, Beni Mellal, Morocco
| | - Mohammed Moukhlissi
- Faculty of Medicine, Mohammed Premier University, Oujda, Morocco
- Department of Radiotherapy, Hassan II Oncology Center, CHU Mohammed VI, PK8 Jerada Rd, 60000, Oujda, Morocco
| | - Tijani El Harroudi
- Faculty of Medicine, Mohammed Premier University, Oujda, Morocco
- Department of Oncological Surgery, Hassan II Oncology Center, CHU Mohammed VI, Oujda, Morocco
| | - Loubna Mezouar
- Faculty of Medicine, Mohammed Premier University, Oujda, Morocco
- Department of Radiotherapy, Hassan II Oncology Center, CHU Mohammed VI, PK8 Jerada Rd, 60000, Oujda, Morocco
| |
Collapse
|
15
|
Berhili S, Guerrouaz MA, Terrab FZ, Moukhlissi M, Mezouar L. Immediate Versus Salvage Postoperative Radiotherapy in High-Risk Prostate Cancer Patients: A Critical Review. Cureus 2022; 14:e27678. [PMID: 36134086 PMCID: PMC9481222 DOI: 10.7759/cureus.27678] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 08/04/2022] [Indexed: 11/30/2022] Open
Abstract
Radical prostatectomy in high-risk prostate cancer patients has long been followed by immediate adjuvant radiotherapy (IART) to increase biochemical relapse-free survival. However, the increased urinary and digestive radio-induced toxicities have raised questions about the safety of delaying radiotherapy until the occurrence of biochemical or clinical relapse. Recently, early salvage radiotherapy (ESRT) has been compared to IART, and results found equivalence in terms of efficiency outcomes, but increased toxicity was noted in patients receiving IART, leading to the proposal of ESRT as the new standard of care in high-risk patients after surgery. However, several confounding points are discussed in the present review regarding the methodology and results of these recent trials. Further follow-up is necessary to detect possible long-term advantages of one radiotherapy timing over the other.
Collapse
|
16
|
Berhili S, Guerrouaz MA, Oulhouq Y, Terrab FZ, Moukhlissi M, Idrissi FEAE, Mezouar L. Sino-nasal low-grade chondrosarcoma revealed by isolated bilateral loss of sight: an unprecedented presentation of a rare tumour. Radiol Case Rep 2022; 17:2563-2567. [PMID: 35634018 PMCID: PMC9130089 DOI: 10.1016/j.radcr.2022.04.026] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2022] [Revised: 04/12/2022] [Accepted: 04/13/2022] [Indexed: 11/29/2022] Open
Abstract
Chondrosarcomas are malignant cartilage-forming tumors representing less than 0.1% of all head and neck malignancies, and nasal cavity is an exceptional location among them. Clinical presentation could be consisting of either rhinological signs or asymptomatic endonasal mass. None of the previous reports mentioned ophthalmological symptoms at the forefront of the initial presentation. We report a case of sino-nasal low-grade chondrosarcoma in a patient who presented initially with isolated bilateral subtotal blindness, managed by endoscopic resection and adjuvant radiotherapy.
Collapse
|
17
|
Berhili S, Rezzoug M, Ben Sghier A, Moukhlissi M, Mezouar L. Oral Malignant Melanoma in a Patient With Neurofibromatosis Type 1: An Extremely Rare Association. Cureus 2022; 14:e25331. [PMID: 35761911 PMCID: PMC9232212 DOI: 10.7759/cureus.25331] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 05/25/2022] [Indexed: 11/05/2022] Open
Abstract
Neurofibromatosis type 1 (NF1) is a genetic disorder associated with high rates of neural crest-derived tumors, both benign and malignant. Many series have identified cutaneous melanoma as a rare tumor among cancers occurring in individuals with NF1 disease, but the mucosal location has to date never been reported. In this paper, we report an oral melanoma occurring in a patient with NF1 disorder, diagnosed at a locally advanced stage, successfully managed by definitive external beam radiotherapy, along with a comprehensive literature review on the melanoma-NF1 association.
Collapse
|
18
|
Guerrouaz MA, Kharkhach A, Miry A, Harroudi TE, Sbai A, Mezouar L. [Recurrent Darier-Ferrand dermatofibrosarcoma in the abdominal wall: the role of preoperative radiotherapy (case report)]. Pan Afr Med J 2022; 41:234. [PMID: 35721637 PMCID: PMC9167487 DOI: 10.11604/pamj.2022.41.234.22764] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/10/2020] [Accepted: 04/24/2020] [Indexed: 11/13/2022] Open
Abstract
Dermatofibrosarcoma is a rare cancer, accounting for 0.01% of all cancers. We here report the case of a 44-year-old female patient presenting with the 5th recurrence of locally advanced Darier-Ferrand dermatofibrosarcoma, that progressed on many cycles of neoadjuvant therapy and required emergency radiotherapy with good response. This allowed to perform wide excision of the tumor with healthy limits. The patient had remission after 1 year of follow-up. Prognosis for patients with Darier-Ferrand dermatofibrosarcoma is generally excellent. Wide surgery and the advent of Mohs surgery have improved local control. The role of radiotherapy is limited for non-resectable tumors or positive margins.
Collapse
Affiliation(s)
| | - Ayoub Kharkhach
- Service de Chirurgie Générale, CHU Mohammed VI, Oujda, Maroc
| | - Achraf Miry
- Service d´Anatomo-Pathologie, CHU Mohammed VI, Oujda, Maroc
| | | | - Ali Sbai
- Service de Radiothérapie, CHU Mohammed VI, Oujda, Maroc
| | | |
Collapse
|
19
|
Moukhlissi M, Sghier AB, Bensaid M, Mezouar L. [Sacrococcygeal chordoma: about a case]. Pan Afr Med J 2022; 40:164. [PMID: 34970406 PMCID: PMC8683457 DOI: 10.11604/pamj.2021.40.164.30316] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/12/2021] [Accepted: 08/13/2021] [Indexed: 11/22/2022] Open
Abstract
Le chordome sacrococcygien est une entité pathologique rare, rapporté dans seulement moins de 3% des cas. Nous allons rapporter l´observation d´une patiente prise en charge au Centre Régional d'Oncologie d'Oujda au Maroc ayant présenté un chordome sacrococcygien localement avancé. Le traitement a consisté en une radiothérapie exclusive sur la tumeur, la chirurgie d´exérèse n´était pas possible. Actuellement la patiente est à 2 ans de recul, la tumeur est stable sur le plan clinique et radiologique avec un bon état général.
Collapse
Affiliation(s)
- Mohamed Moukhlissi
- Département de Radiothérapie, Centre Hospitalier Universitaire Mohammed VI, Faculté de Médecine et de Pharmacie, Université Mohammed 1er, Oujda, Maroc
| | - Ahmed Ben Sghier
- Département de Radiothérapie, Centre Hospitalier Universitaire Mohammed VI, Faculté de Médecine et de Pharmacie, Université Mohammed 1er, Oujda, Maroc
| | | | - Loubna Mezouar
- Département de Radiothérapie, Centre Hospitalier Universitaire Mohammed VI, Faculté de Médecine et de Pharmacie, Université Mohammed 1er, Oujda, Maroc
| |
Collapse
|
20
|
Oulhouq Y, Bakari D, Krim DE, Zerfaoui M, Rrhioua A, Berhili S, Mezouar L. Dosimetric study of Hounsfield number correction effect in areas influenced by contrast product in lungs case. Rep Pract Oncol Radiother 2021; 26:590-597. [PMID: 34434575 PMCID: PMC8382071 DOI: 10.5603/rpor.a2021.0083] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/22/2020] [Accepted: 02/27/2021] [Indexed: 01/24/2023] Open
Abstract
BACKGROUND The aim of the study was dosimetric effect quantification of exclusive computed tomography (CT) use with an intravenous (IV) contrast agent (CA ), on dose distribution of 3D-CRT treatment plans for lung cancer. Furthermore, dosimetric advantage investigation of manually contrast-enhanced region overriding, especially the heart. MATERIALS AND METHODS Ten patients with lung cancer were considered. For each patient two planning CT sets were initially taken with and without CA. Treatment planning were optimized based on CT scans without CA. All plans were copied and recomputed on scans with CA. In addition, scans with IV contrast were copied and density correction was performed for heart contrast enhanced. Same plans were copied and replaced to undo dose calculation errors that may be caused by CA. Eventually, dosimetric evaluations based on dose volume histograms (DVHs) of planning target volumes (PTV) and organs at-risk were studied and analyzed using the Wilcoxon's signed rank test. RESULTS There is no statistically significant difference in dose calculation for the PTV maximum, mean, minimum doses, spinal cord maximum doses and lung volumes that received 20 and 30 Gy, between planes calculated with and without contrast scans (p > 0.05) and also for contrast scan, with manual regions overriding. CONCLUSIONS Dose difference caused by the contrast agent is negligible and not significant. Therefore, there is no justification to perform two scans, and using an IV contrast enhanced scan for dose calculation is sufficient.
Collapse
Affiliation(s)
- Yassine Oulhouq
- LPMR, Faculty of Sciences, University Mohamed 1st, Oujda, Morocco,HASSAN II Oncology Center, University Hospital Mohammed VI, Oujda, Morocco
| | - Dikra Bakari
- National School of Applied Sciences, University Mohamed 1st, Oujda, Morocco
| | - Deae-Eddine Krim
- LPMR, Faculty of Sciences, University Mohamed 1st, Oujda, Morocco
| | | | - Abdeslem Rrhioua
- LPMR, Faculty of Sciences, University Mohamed 1st, Oujda, Morocco
| | - Soufiane Berhili
- HASSAN II Oncology Center, University Hospital Mohammed VI, Oujda, Morocco
| | - Loubna Mezouar
- HASSAN II Oncology Center, University Hospital Mohammed VI, Oujda, Morocco
| |
Collapse
|
21
|
Guerrouaz MA, Samba S, BenSghier A, Sbai A, Mezouar L. Breast Metastasis From a Non-small Cell Lung Cancer: A Case Report. Cureus 2020; 12:e7460. [PMID: 32351839 PMCID: PMC7188011 DOI: 10.7759/cureus.7460] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022] Open
Abstract
Although primary breast cancer (BC) is the most frequent cancer in the world, their mammary metastases are rare. In this paper, we report the case of a 51-year-old male patient diagnosed with a mammary lump and an intracranial hypertension syndrome. Mammography showed the presence of an irregular opacity without microcalcifications. After a cytological and immunohistochemical examination, the breast biopsy showed an adenocarcinoma of pulmonary origin. Computed tomography (CT) scans of the cerebrum, cervicothoracic spine, and abdomen showed a right apical pulmonary tumor associated with Barety's lymphadenopathy, as well as the presence of a mass in the right breast and secondary brain lesions. The patient received total brain irradiation which resulted in a marked clinical improvement. Afterward, he was treated with six cycles of palliative chemotherapy based on carboplatin area under the curve (AUC) 6 and paclitaxel, 175 mg/m² every 21 days, with a good response. After two months, the patient presented with a progression and he was treated with second-line chemotherapy. However, after three chemotherapy courses, the disease rapidly progressed and the patient was altered which required his admission to the palliative care department. The patient died 40 days later. This case shows the poor prognostic survival outcomes in this population of patients.
Collapse
Affiliation(s)
| | - Soumiya Samba
- Department of Radiation Oncology, Centre Hospitalier Universitaire Mohammed Vi, Oujda, MAR
| | - Ahmed BenSghier
- Department of Radiation Oncology, Centre Hospitalier Universitaire Mohammed Vi, Oujda, MAR
| | - Ali Sbai
- Department of Radiation Oncology, Centre Hospitalier Universitaire Mohammed Vi, Oujda, MAR
| | - Loubna Mezouar
- Department of Radiation Oncology, Centre Hospitalier Universitaire Mohammed Vi, Oujda, MAR
| |
Collapse
|
22
|
Belmokhtar KY, Tajir M, Boulouiz R, Bennani A, Brahmi SA, Alloubi I, Kouismi H, Kamaoui I, Skiker I, Afqir S, Abda N, Bellaoui M, Mezouar L. [Lung cancer in Eastern Morocco: where do we stand?]. Pan Afr Med J 2019; 34:177. [PMID: 32153717 PMCID: PMC7046119 DOI: 10.11604/pamj.2019.34.177.19934] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/31/2019] [Accepted: 10/29/2019] [Indexed: 01/22/2023] Open
Abstract
Introduction Lung cancer is the most common cancer in men living Eastern Morocco. We here present the first report on the clinical, pathological and therapeutic features of lung cancer in Eastern Morocco. Methods We conducted a retrospective study of 738 patients diagnosed with lung cancer at the Hassan II, Oncology Center between October 2005 and December 2014. Results Among the cases studied, 671 patients were men and 67 women; 95.01% of men and 1.54% of women were smokers. The average age of patients was 59.1 ± 11.9 years. Most patients (97%) were diagnosed at advanced stage disease. Only 4 out of 227 patients with advanced adenocarcinoma underwent molecular test. In addition, no patient in our series received targeted therapy. In this series, 20.46% of patients had less than 50 years. Compared to patients aged 50 years and older, cannabis consumption was higher (p<0.001) in patients less than 50 years and as well as a higher rate of adenocarcinoma (p<0.01). By contrast, in these patients, tobacco consumption was lower (p<0.001) as well as the rate of squamous cell carcinoma (p<0.01) and small cell cancer (p<0.05). Conclusion Unlike Western countries, in Eastern Morocco lung cancer is diagnosed late, affects younger people and access to molecular tests is still very limited. These results justify the need to implement effective programs against lung cancer as well as to facilitate access to molecular tests and new therapeutic tools in Eastern Morocco.
Collapse
Affiliation(s)
- Karam Yahya Belmokhtar
- Genetics Unit, Faculty of Medicine and Pharmacy of Oujda, University Mohammed Premier, Oujda, Morocco
| | - Mariam Tajir
- Genetics Unit, Faculty of Medicine and Pharmacy of Oujda, University Mohammed Premier, Oujda, Morocco
| | - Redouane Boulouiz
- Genetics Unit, Faculty of Medicine and Pharmacy of Oujda, University Mohammed Premier, Oujda, Morocco
| | - Amal Bennani
- Genetics Unit, Faculty of Medicine and Pharmacy of Oujda, University Mohammed Premier, Oujda, Morocco
| | - Sami Aziz Brahmi
- Faculty of Medicine and Pharmacy of Oujda, University Mohammed Premier, Mohammed VI University Hospital, Oujda, Morocco.,Hassan II Oncology Center, Oujda, Morocco
| | - Ihsan Alloubi
- Faculty of Medicine and Pharmacy of Oujda, University Mohammed Premier, Mohammed VI University Hospital, Oujda, Morocco
| | - Hatim Kouismi
- Faculty of Medicine and Pharmacy of Oujda, University Mohammed Premier, Mohammed VI University Hospital, Oujda, Morocco
| | - Imane Kamaoui
- Faculty of Medicine and Pharmacy of Oujda, University Mohammed Premier, Mohammed VI University Hospital, Oujda, Morocco
| | - Imane Skiker
- Faculty of Medicine and Pharmacy of Oujda, University Mohammed Premier, Mohammed VI University Hospital, Oujda, Morocco
| | - Said Afqir
- Faculty of Medicine and Pharmacy of Oujda, University Mohammed Premier, Mohammed VI University Hospital, Oujda, Morocco.,Hassan II Oncology Center, Oujda, Morocco
| | - Naima Abda
- Faculty of Medicine and Pharmacy of Oujda, University Mohammed Premier, Mohammed VI University Hospital, Oujda, Morocco
| | - Mohammed Bellaoui
- Genetics Unit, Faculty of Medicine and Pharmacy of Oujda, University Mohammed Premier, Oujda, Morocco
| | - Loubna Mezouar
- Faculty of Medicine and Pharmacy of Oujda, University Mohammed Premier, Mohammed VI University Hospital, Oujda, Morocco.,Hassan II Oncology Center, Oujda, Morocco
| |
Collapse
|
23
|
Naim A, Benali I, Chihabbedine M, Kouhen F, Saidi K, Krabech A, Mansouri S, Aitouam H, Moukhlissi M, Rahmouni A, Mezouar L, Sabri S, Khouchani M. Apport des faisceaux tangentiels dans l’irradiation axillaire pour le cancer du sein : étude multicentrique nationale marocaine. Cancer Radiother 2019. [DOI: 10.1016/j.canrad.2019.07.069] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
24
|
Sbai A, Dahbi Z, Naciri F, Elmejjatti F, Guerouaz A, Lakhmis K, Guezzar M, Allouch F, Mezouar L. [Six-year disease-free survival after chemotherapy treatment for metastatic renal peripheral neuroectodermal tumor]. Pan Afr Med J 2019; 32:42. [PMID: 31143347 PMCID: PMC6522208 DOI: 10.11604/pamj.2019.32.42.12475] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/10/2017] [Accepted: 10/01/2018] [Indexed: 11/11/2022] Open
Abstract
Peripheral neuroectodermal tumors (PNET) of the kidney are extremely rare. They are often diagnosed at a late stage due to their nonspecific clinical presentation. Treatment of patients with metastases is based on palliative chemotherapy. We here report a case of PNET of the kidney with sudden onset of metastases to the lymph nodes and to the skin. The patient showed good clinical and radiological response and experienced progression-free survival at 6 years after polychemotherapy with vincristine, doxorubicin and cyclophosphamide.
Collapse
Affiliation(s)
- Ali Sbai
- Service de Radiothérapie, Centre Hospitalier Universitaire Oujda, Maroc
| | - Zineb Dahbi
- Service de Radiothérapie, Centre Hospitalier Universitaire Oujda, Maroc
| | - Farid Naciri
- Service de Radiothérapie, Centre Hospitalier Universitaire Oujda, Maroc
| | - Fouad Elmejjatti
- Service de Radiothérapie, Centre Hospitalier Universitaire Oujda, Maroc
| | - Amine Guerouaz
- Service de Radiothérapie, Centre Hospitalier Universitaire Oujda, Maroc
| | - Kawtar Lakhmis
- Service de Radiothérapie, Centre Hospitalier Universitaire Oujda, Maroc
| | - Mohammed Guezzar
- Service de Radiothérapie, Centre Hospitalier Universitaire Oujda, Maroc
| | - Fadwa Allouch
- Service de Radiothérapie, Centre Hospitalier Universitaire Oujda, Maroc
| | - Loubna Mezouar
- Service de Radiothérapie, Centre Hospitalier Universitaire Oujda, Maroc
| |
Collapse
|
25
|
Dahbi Z, Elmejjatti F, Naciri F, Guerouaz A, Oabdelmoumen A, Sbai A, Mezouar L. [Vulvar cancer treatment options: experience in the Oncology Center in Oujda]. Pan Afr Med J 2019; 31:182. [PMID: 31086633 PMCID: PMC6488234 DOI: 10.11604/pamj.2018.31.182.13812] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/07/2017] [Accepted: 10/01/2018] [Indexed: 11/23/2022] Open
Abstract
Le cancer de la vulve est une affection néoplasique rare, représentant moins de 5% des cancers génitaux de la femme. L'objectif de ce travail est de décrire le profil épidémiologique, clinique, paraclinique, thérapeutique et évolutif du cancer de la vulve chez la population de la région de l'Oriental du Maroc, ceci à travers une analyse rétrospective de toutes les patientes suivies pour un cancer de la vulve, de juin 2007 à janvier 2014, et traitées au sein de l'hôpital d'Oncologie du Centre Hospitalier Universitaire Mohamed VI de Oujda au Maroc. Notre analyse rétrospective a porté sur 34 patientes, d'une médiane d'âge de 65,7 ans, dont 52,9% étaient des multipares. Le motif de consultation dominant était le prurit dans 94.1% des cas. La moyenne du délai de consultation était de 16 mois, allant de 2 mois à 8 ans. L'ignorance et la pudeur ont été les causes majeures de ce retard diagnostique, puisque 73.5% des patientes avaient déjà une maladie localement avancée au diagnostic. Le traitement chirurgical a été proposé à 61.4% des cas, il a consisté en une vulvectomie radicale avec un curage inguinal bilatéral dans 68.5% des cas. Le recours à la radiothérapie adjuvante a été indiqué chez 41.2% des cas, 5.9% des patientes ont bénéficié d'une radiothérapie néo adjuvante, et 20,6% d'une radiothérapie exclusive associée à une chimiothérapie concomitante. La chimiothérapie palliative a été proposée pour 8.8% des patientes. Le taux de survie globale à 3 ans est à 65%, le taux de récidives locorégionales ou à distance est de 17.3% des cas. Les particularités culturelles et sociales des patientes de la région de l'Oriental du Maroc, qui sont suivies pour un cancer de la vulve, sont des facteurs influençant le traitement et ses résultats. Des efforts de prévention et de sensibilisation supplémentaires sont à mener afin de réduire l'incidence des stades localement avancés, et de permettre un traitement curatif à cette population.
Collapse
Affiliation(s)
- Zineb Dahbi
- Service de Radiothérapie, Centre Hospitalier Universitaire d'Oujda, Oujda, Maroc
| | - Fouad Elmejjatti
- Service de Radiothérapie, Centre Hospitalier Universitaire d'Oujda, Oujda, Maroc
| | - Farid Naciri
- Service de Radiothérapie, Centre Hospitalier Universitaire d'Oujda, Oujda, Maroc
| | - Amine Guerouaz
- Service de Radiothérapie, Centre Hospitalier Universitaire d'Oujda, Oujda, Maroc
| | - Asmae Oabdelmoumen
- Service de Radiothérapie, Centre Hospitalier Universitaire d'Oujda, Oujda, Maroc
| | - Ali Sbai
- Service de Radiothérapie, Centre Hospitalier Universitaire d'Oujda, Oujda, Maroc
| | - Loubna Mezouar
- Service de Radiothérapie, Centre Hospitalier Universitaire d'Oujda, Oujda, Maroc
| |
Collapse
|
26
|
Berhili S, Ouabdelmoumen A, Sbai A, Kebdani T, Benjaafar N, Mezouar L. Radical Mastectomy Increases Psychological Distress in Young Breast Cancer Patients: Results of A Cross-sectional Study. Clin Breast Cancer 2019; 19:e160-e165. [DOI: 10.1016/j.clbc.2018.08.013] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/26/2018] [Revised: 08/28/2018] [Accepted: 08/29/2018] [Indexed: 10/28/2022]
|
27
|
Dahbi Z, Sbai A, Mezouar L. [Thyroid function after hypofractionated adjuvant radiotherapy for localized breast cancer]. Cancer Radiother 2019; 23:34-37. [PMID: 30595341 DOI: 10.1016/j.canrad.2018.04.004] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/27/2018] [Revised: 04/16/2018] [Accepted: 04/18/2018] [Indexed: 11/29/2022]
Abstract
PURPOSE We aimed to evaluate the impact on the thyroid function of hypofractionated adjuvant radiotherapy of localized breast cancer. MATERIAL AND METHOD This was a prospective study, including 50 patients with breast cancer treated by hypofractionated adjuvant radiation, only half of whom received radiotherapy on the supraclavicular region. The analysis focused on clinical, dosimetric and biological data collected through periodic dosing of thyroid hormones. RESULTS The incidence of hypothyroidism was 4% of the patients. The multivariate correlation analysis showed a significant association between initial thyroid volume, volume receiving 50Gy, 40Gy and 30Gy and the incidence of hypothyroidism, no statistical link was found between the bilateral breast, chemotherapy, hormone therapy and the type of surgery and the incidence of radiation-induced hypothyroidism. CONCLUSION Although hypofractionation theoretically exposes the thyroid gland to late radiotherapy complications, radiation-induced dysthyroidism remains a complication underestimated by clinicians, and in the absence of prevention and treatment guidelines, it is necessary to delineate systematically the thyroid gland, to try to minimize as much as possible the doses received by this organ, and to monitor the thyroid function by periodic serum assays.
Collapse
Affiliation(s)
- Z Dahbi
- Radiothérapie oncologie, hôpital universitaire Mohammed-VI, BP 2013, Oued Nachef, Oujda, Maroc.
| | - A Sbai
- Radiothérapie oncologie, hôpital universitaire Mohammed-VI, BP 2013, Oued Nachef, Oujda, Maroc
| | - L Mezouar
- Radiothérapie oncologie, hôpital universitaire Mohammed-VI, BP 2013, Oued Nachef, Oujda, Maroc
| |
Collapse
|
28
|
Abstract
Introduction: This is a prospective study aiming to describe how cervical cancer and its treatment can affect the sexuality of a specific population of Moroccan women survivors of this disease. Materiels and Methods: It is a comparison of clinical features and Female Sexual Function Index (FSFI) of 3 balanced groups of women, made up of 100 survivors of cervical cancer, 100 survivors of non-gynecological cancer and a group of 100 healthy women. Results: 97% of the patients stopped their full sexual activity at the time of treatment; the time interval between treatment and regular sexual activity was 8 months for the cervical cancer group, and 5.8 months for non-gynecologic cancer (P =0.001). Vaginal length assessed by pelvic examination during follow up visits was estimated at about 6.2 cm, 9.2 cm and 9.5 cm respectively for the cervical cancer group, non-gynecologic cancer group and the control group (p=0.04). On the basis of the FSFI questionnaire, the analysis of the 6 main sexuality parameter scores did attest worse results for the variables related to sexual function for cervical cancer group, but not in a statistically significant way. Conclusion: In order to preserve an optimal quality of life after cervical cancer, the sexual dimension is a crucial parameter to take into consideration throughout treatment phases, especially radiation (by encouraging sexual intercourses, and using vaginal dilators during the treatment). Moroccan survivors of this disease must be treated according to a multidisciplinary approach, that includs the psychological component.
Collapse
Affiliation(s)
- Zineb Dahbi
- Department of Radiation Oncology, University Hospital Mohammed VI, Oujda, Morocco.
| | | | | |
Collapse
|
29
|
Ouabdelmoumen A, Sbai A, Elmejjatti F, Bourhaleb Z, Abda N, Mezouar L. Predictive Factors of Histological Response after Preoperative Concomitant Radiochemotherapy in Middle and Low Rectal Cancer. Asian Pac J Cancer Care 2018. [DOI: 10.31557/apjcc.2018.3.3.65] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
Abstract
Objective: The aim of our study was to identify potential predictive factors beyond pathologic response after neoadjuvant radiochemotherapy.Patients and Methods: Between January 2009 and December 2014, 40 patients with rectal carcinoma were included in the study. The treatment consisted of radiation ranging between 39 and 50.4 Gy associated with a concomitant chemotherapy with capecitabine. The correlation between histological response (complete response and downstaging) and potential predictive factors were investigated.Results: Complete response was 15% (06 patients), tumor regression of 32.5% (13 patients), and the absence of tumor response of 52.5% (21 patients). In univariate analysis, the circumferential extension of the tumor was significantly associated with tumor downstaging (p = 0.007) and complete tumor response (p = 0.001). However, the delay between the RCT and the surgery was a significant predictor for downstaging (p = 0.02).Conclusion: the parietal circumferential extension was a potential predictor of pathologic complete response (PCR) and downstaging after neoadjuvant chemoradiation. The time between the radiochemotherapy and the surgery was a significant predictor for downstaging. Delaying surgery beyond 8 weeks seems to result in the highest probability of PCR.
Collapse
|
30
|
Sbai A, Ouabdelmoumene A, Naciri F, Elhfid M, Mezouar L. [Non gestational endometrial choriocarcinoma in a nulliparous and postmenopausal woman: report of a case]. Pan Afr Med J 2014; 17:278. [PMID: 25317226 PMCID: PMC4194206 DOI: 10.11604/pamj.2014.17.278.3476] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/14/2013] [Accepted: 12/09/2013] [Indexed: 11/24/2022] Open
Abstract
Le choriocarcinome est une tumeur trophoblastique hautement maligne. La plupart des cas de choriocarcinome sont intra utérins et d'origine gestationnelle. Le choriocarcinome chez les femmes ménopausées est extrêmement rare. Nous rapportons une observation originale d'une femme ménopausée et nullipare présentant un choriocarciome endometrial non gestationnel survenant 17 ans après sa ménopause. Il n'existe pas de guidelines bien définis pour le traitement des choriocarcinomes en post ménopause. Leur pronostic est très facheux, pourtant il paraît que le stade précoce de la maladie ainsi que les béta hCG plasmatiques négatives seraient à l'origine de ces survies: globale et sans progression relativement longues chez notre patiente (32 mois).
Collapse
Affiliation(s)
- Ali Sbai
- Centre régional d'oncologie Hassan-2-Oujda, Maroc
| | | | - Farid Naciri
- Centre régional d'oncologie Hassan-2-Oujda, Maroc
| | - Mohammed Elhfid
- Centre régional d'oncologie Hassan-2-Oujda, Maroc ; Faculté de Médecine et de Pharmacie, Université Mohammed Premier,Oujda, Maroc
| | - Loubna Mezouar
- Centre régional d'oncologie Hassan-2-Oujda, Maroc ; Faculté de Médecine et de Pharmacie, Université Mohammed Premier,Oujda, Maroc
| |
Collapse
|
31
|
Abstract
L'hidradénocarcinome est une tumeur annexielle maligne extrêmement rare. Caractérisée par la fréquence des récidives locorégionales et des métastases à distance. Le diagnostic histopathologique de malignité se fait sur des critères architecturaux et cytologiques particuliers .la chirurgie d'exérèse large représente l'essentiel du traitement. Une radiothérapie adjuvante s'avère obligatoire en cas de facteurs de récidive locale. Le curage ou la radiothérapie prophylactiques des aires ganglionnaires régionales non envahies pourraient jouer un rôle primordial dans la réduction du risque de récidives locorégionales.
Collapse
Affiliation(s)
- Ali Sbai
- Centre Régional d'Oncologie Hassan II, Oujda, Maroc
| | | | - Farid Naciri
- Centre Régional d'Oncologie Hassan II, Oujda, Maroc
| | - Mohammed Elhfid
- Centre Régional d'Oncologie Hassan II, Oujda, Maroc ; Faculté de Médecine et de Pharmacie, Université Mohammed Premier,Oujda, Maroc
| | - Loubna Mezouar
- Centre Régional d'Oncologie Hassan II, Oujda, Maroc ; Faculté de Médecine et de Pharmacie, Université Mohammed Premier,Oujda, Maroc
| |
Collapse
|
32
|
Ouabdelmoumen A, Naciri F, Mezouar L, Elhfid M. Aspects thérapeutiques et évolutifs des thymomes invasifs, à propos de cinq cas. Cancer Radiother 2013. [DOI: 10.1016/j.canrad.2013.07.069] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
33
|
Harroudi TE, Bouziane M, Abbaoui S, Elhfid M, Mezouar L. Endometrial Mixed Müllerian Tumor Following Tamoxifen Therapy for Breast Cancer: A Case Report. J Gynecol Surg 2012. [DOI: 10.1089/gyn.2010.0057] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
| | | | | | - Mohammed Elhfid
- Department of Radiotherapy, Regional Center of Oncology, Oujda, Morocco
| | - Loubna Mezouar
- Department of Radiotherapy, Regional Center of Oncology, Oujda, Morocco
| |
Collapse
|